Literature DB >> 27858335

GOLM1-regulated EGFR/RTK recycling is a novel target for combating HCC metastasis.

Wenwei Zhu1, Lunxiu Qin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27858335     DOI： 10.1007/s11427-016-0311-x

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  7 in total

Review 1.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

2.  MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Authors:  Shukun Zhang; Wenmin Ge; Gangyong Zou; Lin Yu; Yongcun Zhu; Qiujing Li; Yujie Zhang; Zhanli Wang; Tao Xu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

3.  Overexpression of golgi membrane protein 1 promotes non-small-cell carcinoma aggressiveness by regulating the matrix metallopeptidase 13.

Authors:  Li Mei Li
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.

Authors:  Xi Liu; Lei Chen; Tao Zhang
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

5.  STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis.

Authors:  Xi-Wu Zhang; Qiu-Han Li; Zuo-di Xu; Jin-Jin Dou
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

6.  Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior.

Authors:  Xiaohai Liu; Ming Feng; Congxin Dai; Xinjie Bao; Kan Deng; Yong Yao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-14       Impact factor: 5.555

7.  Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab.

Authors:  Yu Wang; Meng Zhang; Yixin Gong; Qiyan Wu; Lijun Zhang; Shunchang Jiao
Journal:  Int J Gen Med       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.